Recent research suggests that Cyberlindnera jadinii and Kluyveromyces lactis, two yeasts commonly used in food production, could offer probiotic benefits, particularly in reducing gut inflammation. This discovery opens up possibilities for novel treatments for inflammatory bowel conditions.
Fungi, including various yeasts, have been integral to the food industry for their roles in fermentation and flavor enhancement. A new study, now published in mSystems by the American Society for Microbiology, highlights the potential of these two food-based fungi in combating gut inflammation, signaling a new direction in probiotic development.
Lead researcher, Dr. Mathias L. Richard of INRAE at the Micalis Institute, France, emphasizes the importance of exploring the health impacts of these food-processing fungal strains, as they may be sources of novel probiotics.
Exploring the Role of Yeasts in Nutrition and Health
The diversity and health implications of foodborne yeasts remain largely unexplored. These microscopic fungi, which reproduce through budding, have been employed for centuries in various food productions like wine, bread, and cheese ripening.
The latest study aims to deepen understanding of how these fungi affect human health, particularly concerning gut health and inflammatory bowel diseases. The research team focused on the fungi used in food industries, such as in cheese and meat products, analyzing their effects on gut health through both in vitro and in vivo models.
Investigating the Probiotic Nature of Culinary Yeasts
The research involved selecting a range of yeasts heavily used in food production for testing. The team conducted experiments with human cell cultures and animal models of ulcerative colitis.
The study identified two yeast strains, Cyberlindnera jadinii and Kluyveromyces lactis, that showed promise in alleviating inflammatory symptoms in a mouse model of ulcerative colitis. Further research sought to unravel the mechanisms behind these effects. For instance, the administration of C. jadinii appeared to alter the gut’s bacterial microbiota, influencing inflammation sensitivity through an as-yet-unknown process.
Dr. Richard notes the novelty of these strains in exerting such beneficial effects, emphasizing the need for further research, particularly regarding their efficacy in humans.
In summary, Cyberlindnera jadinii and Kluyveromyces lactis hold potential as probiotic yeasts in treating gut inflammation, but further studies are required to fully understand their impact on gut health.
Reference: Cindy Hugot et al., “Cyberlindnera jadinii and Kluyveromyces lactis, two fungi used in food processes, have potential probiotic effects on gut inflammation,” mSystems, 26 October 2023. DOI: 10.1128/msystems.00841-23.
Table of Contents
Frequently Asked Questions (FAQs) about Probiotic Yeasts
What are the two yeasts mentioned in the study for potential probiotic properties?
Cyberlindnera jadinii and Kluyveromyces lactis are the two yeasts mentioned in the study, known for their potential probiotic properties beneficial for gut inflammation.
How might these yeasts impact the treatment of inflammatory bowel diseases?
The study suggests that these yeasts could lead to new treatments for inflammatory bowel diseases by reducing gut inflammation due to their probiotic properties.
What is the significance of these yeasts in the food industry?
These yeasts, Cyberlindnera jadinii and Kluyveromyces lactis, have been long used in the food industry for fermentation and flavor production, and are now recognized for their potential health benefits.
What does the research say about the diversity of foodborne yeasts and gut health?
The research highlights that the diversity of foodborne yeasts and their effects on gut microbiota and health are not well understood, indicating a need for further study in this area.
What were the methods used in this research study?
The study involved selecting a range of yeasts used in food production and testing their effects on human cell cultures and animal models mimicking ulcerative colitis.
What are the potential benefits of Cyberlindnera jadinii and Kluyveromyces lactis?
These two strains of yeasts have shown potential benefits in reducing inflammatory symptoms in a mouse model of ulcerative colitis and might alter gut bacterial microbiota to influence inflammation.
More about Probiotic Yeasts
- Probiotic Benefits of Yeasts
- Cyberlindnera jadinii and Gut Health
- Kluyveromyces lactis in Inflammatory Bowel Disease Treatment
- Yeasts in Food Production and Health
- Study on Foodborne Yeasts and Ulcerative Colitis
- Understanding Yeasts’ Role in Gut Microbiota
5 comments
this article needs more detail on how exactly these yeasts reduce inflammation, like what’s the science behind it??
I’m a bit skeptical, how can something used in cheese and bread be good for IBD sufferers, doesn’t dairy and gluten cause problems for them usually?
the reference to ulcerative colitis model in mice is a bit confusing, does it mean these yeasts will have the same effect in humans or is more research needed?
wow, this is really interesting! never knew that the yeasts we use in food could help with gut health, always thought they were just for flavor.
great article but the title could be more catchy, something like “Miracle Yeasts: The Future of Gut Health?” might attract more readers.